China Medical & HealthCare Group Limited provided consolidated earnings guidance for the eleven months ended 30 November 2022. For the period, the company group is expected to record a loss attributable to shareholders of the Company ("Net Loss") for the eleven months ended 30 November 2022 which represents (a) an approximately 26% decrease as compared with the Net Loss for the corresponding period in 2021; (b) an approximately 30% to 50% decrease when compared with the Net Loss for the year ended 31 December 2021; but (c) an approximately 20% to 40% increase when compared with the Net Loss for the year ended 31 December 2021 excluding the one-off non-recurring item of impairment loss under expected credit loss model recognized on loan receivable.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.68 HKD | -.--% | -.--% | -15.00% |
Mar. 17 | China Medical & HealthCare Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 09 | China Medical & HealthCare to Return to Profit in 2023 | MT |
1st Jan change | Capi. | |
---|---|---|
-15.00% | 94.42M | |
-18.46% | 16.57B | |
+4.50% | 12.4B | |
+4.98% | 11.69B | |
+4.26% | 10.24B | |
-3.16% | 7.76B | |
+20.21% | 7.17B | |
+6.45% | 6.74B | |
+50.68% | 4.65B | |
-5.12% | 4.25B |
- Stock Market
- Equities
- 383 Stock
- News China Medical & HealthCare Group Limited
- China Medical & Healthcare Group Limited Provides Consolidated Earnings Guidance for the Eleven Months Ended 30 November 2022